Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avidity Biosciences (RNA) Amortization of Deferred Charges (2019 - 2020)

Historic Amortization of Deferred Charges for Avidity Biosciences (RNA) over the last 2 years, with Q2 2020 value amounting to $20000.0.

  • Avidity Biosciences' Amortization of Deferred Charges changed N/A to $20000.0 in Q2 2020 from the same period last year, while for Mar 2021 it was $20000.0, marking a year-over-year change of. This contributed to the annual value of $29000.0 for FY2020, which is 5915.49% down from last year.
  • Latest data reveals that Avidity Biosciences reported Amortization of Deferred Charges of $20000.0 as of Q2 2020.
  • Over the past 5 years, Avidity Biosciences' Amortization of Deferred Charges peaked at $27000.0 during Q3 2019, and registered a low of $9000.0 during Q1 2020.